PRKG1 and Parkinson disease: Similarly, a 25-year-old male carrier of a PGK1 mutation that caused a marked decrease in PGK activity presented both exertional myoglobinuria and severe parkinsonism that was responsive to levodopa treatment (Sotiriou et al., 2010).